Prostaglandins Before Caserean Section

Kasr El Aini Hospital

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Intrapartum Hemorrhage

Treatments: Procedure: elective cesarean section; Drug: Misoprostol 200Mcg Tab

Study type: Interventional

Funder types: Other

Identifiers

NCT03366259

4122017

Details and patient eligibility

About

The aim of our study is to assess the value of administration of prostaglandins before cesarean section to reduce the amount of blood loss

Full description

160 full term pregnant patients candidate for elective cesarean section were randomly allocated into 2 groups ,80 patients will receive 200mcg of rectal prostaglandins before cesarean section and 80 patients are used as control receiving placebo

Enrollment: 160 estimated patients

Sex: Female

Ages: 20 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:pregnant patients full term elective cesarean section

Exclusion Criteria:

• medical disorder with pregnancy

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

160 participants in 2 patient groups, including a placebo group

Group A (Misoprostol group)

Active Comparator group

Description:

200 mcg rectal Misoprostol administration before cesarean section

Treatment:

Drug: Misoprostol 200Mcg Tab

Procedure: elective cesarean section

Group B (control group)

Placebo Comparator group

Description:

No prostaglandins administration before cesarean section

Treatment:

Procedure: elective cesarean section